UPDATE: Goldman Sachs Raises PT on Vitamin Shoppe from $56 to $64

Goldman Sachs reiterated a Neutral rating on Vitamin Shoppe

and increased its price target from $56 to $64. Goldman Sachs wrote, “VSI's 2Q results were marked by improved SSS momentum relative to sector data and peers; nice acceleration in e-commerce sales; and, ongoing operating leverage. SSS are now firmly delivering on the potential associated with rapid unit growth.” Vitamin Shoppe closed at $60.52 on Tuesday.